Literature DB >> 19902235

Cadmium and tubular dysfunction marker levels in urine of residents in non-polluted areas with natural abundance of cadmium in Japan.

Jiro Moriguchi1, Yoshiro Inoue, Sigetosi Kamiyama, Sonoko Sakuragi, Masaru Horiguchi, Katsuyuki Murata, Yoshinari Fukui, Fumiko Ohashi, Masayuki Ikeda.   

Abstract

OBJECTIVES: Literature survey has suggested that cadmium (Cd) in the general environment is more abundant in the northern part of the coast on the sea of Japan. The present survey was initiated to examine if the exposure to Cd in the area has been higher than other parts of Japan, and if so, the higher exposure has been associated with tubular dysfunction among the local residents.
METHODS: In three prefectures of Akita, Yamagata and Ishikawa in the region, adult women (about 700 subjects per prefecture) were invited to participate in the survey. Each of the participants provided informed consents, offered spot urine samples and filled questionnaires (on age etc.). The urine samples were analyzed for Cd, alpha(1)-microglobulin (alpha(1)-MG), beta(2)-microglobulin (beta(2)-MG) and N-acetyl-beta-D: -glucosaminidase, together with creatinine and specific gravity. The results were combined with published data on two other prefectures of Niigata and Toyama (both in the area), as well as Japan as a whole (all Japan-A excluding Niigata prefecture, which was studied separately in the present study), and subjected to analysis for possible difference from all Japan-A in terms of the levels of internal Cd burden, and prevalence of beta(2)-MG-uria.
RESULTS: Geometric means (GMs) for urinary Cd in the five prefectures were in a range from a low of 1.20 to a high of 2.65 microg/l, being higher than the GM (0.99 microg/l) for all Japan-A. GMs for alpha(1)-MG (2.15-2.80 mg/l) and beta(2)-MG (99-107 microg/l) were only slightly higher or even lower than all Japan-A values depending on the prefectures. Elevation in the prevalence of beta(2)-MG-uria was significant in Akita prefecture, but the elevation in beta(2)-MG was not associated with elevation in Cd in urine. Literature survey on general population Cd epidemiology showed that Cd, alpha(1)-MG and beta(2)-MG levels in urine of the residents in the five prefectures were within the levels reported for non-polluted areas, and such was also the case for prevalence of beta(2)-MG-uria.
CONCLUSIONS: In an over-all evaluation, no clear-cut evidence was available for increased prevalence of Cd exposure-associated renal tubular dysfunction among general populations in the five prefectures in the northern part on the coast of Sea of Japan than in other prefectures in Japan, despite moderate elevation in urinary Cd levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902235     DOI: 10.1007/s00420-009-0483-9

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  44 in total

1.  Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.

Authors:  Etsuko Kobayashi; Yasushi Suwazono; Mirei Uetani; Takeya Inaba; Mitsuhiro Oishi; Teruhiko Kido; Muneko Nishijo; Hideaki Nakagawa; Koji Nogawa
Journal:  Environ Res       Date:  2006-01-24       Impact factor: 6.498

2.  Biomarkers of metal toxicity in population studies: research potential and interpretation issues.

Authors:  Alfred Bernard
Journal:  J Toxicol Environ Health A       Date:  2008

3.  Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. IV. Current information on interpreting the health implications of tests.

Authors:  A Bernard; H Stolte; M E De Broe; P W Mueller; H Mason; L H Lash; B A Fowler
Journal:  Ren Fail       Date:  1997-07       Impact factor: 2.606

4.  Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration.

Authors:  J Moriguchi; T Ezaki; T Tsukahara; K Furuki; Y Fukui; S Okamoto; H Ukai; H Sakurai; S Shimbo; M Ikeda
Journal:  Toxicol Lett       Date:  2003-08-28       Impact factor: 4.372

5.  Cadmium-induced proximal tubular dysfunction in a cadmium-polluted area.

Authors:  H Saito; R Shioji; Y Hurukawa; K Nagai; T Arikawa
Journal:  Contrib Nephrol       Date:  1977       Impact factor: 1.580

6.  Analysis for threshold levels of cadmium in urine that induce tubular dysfunction among women in non-polluted areas in Japan.

Authors:  T Ezaki; T Tsukahara; J Moriguchi; K Furuki; Y Fukui; H Ukai; S Okamoto; H Sakurai; S Honda; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  2002-12-19       Impact factor: 3.015

7.  Estimation of variation among individuals of biological half-time of cadmium calculated from accumulation data.

Authors:  M Sugita; K Tsuchiya
Journal:  Environ Res       Date:  1995-01       Impact factor: 6.498

8.  Renal effects in children living in the vicinity of a lead smelter.

Authors:  A M Bernard; A Vyskocil; H Roels; J Kriz; M Kodl; R Lauwerys
Journal:  Environ Res       Date:  1995-02       Impact factor: 6.498

9.  Dietary exposure to cadmium at close to the current provisional tolerable weekly intake does not affect renal function among female Japanese farmers.

Authors:  Hyogo Horiguchi; Etsuko Oguma; Satoshi Sasaki; Kayoko Miyamoto; Yoko Ikeda; Munehito Machida; Fujio Kayama
Journal:  Environ Res       Date:  2004-05       Impact factor: 6.498

10.  Threshold levels of urinary cadmium in relation to increases in urinary beta2-microglobulin among general Japanese populations.

Authors:  M Ikeda; T Ezaki; T Tsukahara; J Moriguchi; K Furuki; Y Fukui; H Ukai; S Okamoto; H Sakurai
Journal:  Toxicol Lett       Date:  2003-02-03       Impact factor: 4.372

View more
  7 in total

1.  Variation in benchmark dose (BMD) and the 95% lower confidence limit of benchmark dose (BMDL) among general Japanese populations with no anthropogenic exposure to cadmium.

Authors:  Sonoko Sakuragi; Ken Takahashi; Tsutomu Hoshuyama; Jiro Moriguchi; Fumiko Ohashi; Yoshinari Fukui; Masayuki Ikeda
Journal:  Int Arch Occup Environ Health       Date:  2012-01-24       Impact factor: 3.015

2.  Closer correlation of cadmium in urine than that of cadmium in blood with tubular dysfunction markers in urine among general women populations in Japan.

Authors:  Masayuki Ikeda; Fumiko Ohashi; Yoshinari Fukui; Sonoko Sakuragi; Jiro Moriguchi
Journal:  Int Arch Occup Environ Health       Date:  2010-04-03       Impact factor: 3.015

3.  Relation of child birth and breast-feeding burden with cadmium and tubular dysfunction marker levels in urine of adult women in non-polluted areas in Japan.

Authors:  Masayuki Ikeda; Jiro Moriguchi; Sonoko Sakuragi; Fumiko Ohashi
Journal:  Int Arch Occup Environ Health       Date:  2012-08-10       Impact factor: 3.015

4.  Bi-linear dose--response relationship in general populations with low-level cadmium exposures in non-polluted areas in Japan.

Authors:  Masayuki Ikeda; Jiro Moriguchi; Sonoko Sakuragi; Fumiko Ohashi
Journal:  Int Arch Occup Environ Health       Date:  2011-08-06       Impact factor: 3.015

5.  Association of past diseases with levels of cadmium and tubular dysfunction markers in urine of adult women in non-polluted areas in Japan.

Authors:  Masayuki Ikeda; Jiro Moriguchi; Sonoko Sakuragi; Fumiko Ohashi
Journal:  Int Arch Occup Environ Health       Date:  2012-04-13       Impact factor: 3.015

6.  Urine β 2-Microglobolin in the Patients with Congenital Heart Disease.

Authors:  Noor Mohammad Noori; Simin Sadeghi; Iraj Shahramian; Kambiz Keshavarz
Journal:  Int Cardiovasc Res J       Date:  2013-06-01

7.  Associations between Urinary Excretion of Cadmium and Renal Biomarkers in Nonsmoking Females: A Cross-Sectional Study in Rural Areas of South China.

Authors:  Yun-rui Zhang; Ping Wang; Xu-xia Liang; Chuen Seng Tan; Jian-bin Tan; Jing Wang; Qiong Huang; Rui Huang; Zhi-xue Li; Wen-cai Chen; Shi-xuan Wu; Choon Nam Ong; Xing-fen Yang; Yong-ning Wu
Journal:  Int J Environ Res Public Health       Date:  2015-09-24       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.